Telik
Palo Alto
About Telik
Telik, Inc. is a biopharmaceutical company dedicated to discovering, developing and commercializing novel small molecule drugs to treat cancer and other serious diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $4.6M
- Funding stage: M&A
- Last round: Post-IPO Equity (May 2014)
- Ticker: nasdaq:TELK
- Website: telik.com
- Phone: 6508457800
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/telik-2046220 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.